BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9176098)

  • 1. C2-ceramide and C6-ceramide inhibited priming for enhanced release of superoxide in monocytes, but had no effect on the killing of leukaemic cells by monocytes.
    Nakabo Y; Pabst MJ
    Immunology; 1997 Apr; 90(4):477-82. PubMed ID: 9176098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
    Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
    J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C2-ceramide primes specifically for the superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils.
    Richard A; Bourgoin S; Naccache PH; L'Heureux GP; Krump E; McColl SR; Pelletier G
    Biochim Biophys Acta; 1996 Jan; 1299(2):259-66. PubMed ID: 8555272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine protease inhibitors block priming of monocytes for enhanced release of superoxide.
    Megyeri P; Pabst KM; Pabst MJ
    Immunology; 1995 Dec; 86(4):629-35. PubMed ID: 8567031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages.
    Lakics V; Vogel SN
    J Immunol; 1998 Sep; 161(5):2490-500. PubMed ID: 9725248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylsphingosine (C2-ceramide) inhibited neutrophil superoxide formation and calcium influx.
    Wong K; Li XB; Hunchuk N
    J Biol Chem; 1995 Feb; 270(7):3056-62. PubMed ID: 7852386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide does not mediate the effect of tumour necrosis factor alpha on superoxide generation in human neutrophils.
    Yanaga F; Watson SP
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):733-8. PubMed ID: 8141790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
    Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets.
    Williams MA; Newland AC; Kelsey SM
    Leuk Res; 2000 Apr; 24(4):317-30. PubMed ID: 10713329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils.
    Ahmed N; Berridge MV
    Pharmacol Toxicol; 2000 Mar; 86(3):114-21. PubMed ID: 10752668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C6-ceramide enhances Interleukin-12-mediated T helper type 1 cell responses through a cyclooxygenase-2-dependent pathway.
    Kue CS; Jung MY; Cho D; Kim TS
    Immunobiology; 2012 Jun; 217(6):601-9. PubMed ID: 22112438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold sodium thiomalate (GSTM) inhibits lipopolysaccharide stimulated tumor necrosis factor-alpha through ceramide pathway.
    Kumar Mangalam A; Aggarwal A; Naik S
    Cell Immunol; 2002 Sep; 219(1):1-10. PubMed ID: 12473262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles.
    Kaipia A; Chun SY; Eisenhauer K; Hsueh AJ
    Endocrinology; 1996 Nov; 137(11):4864-70. PubMed ID: 8895358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by sphingosine of leukemic cell killing by human monocytes activated with interleukin-2: a possible role of protein kinase C.
    Nakabo Y; Pabst MJ
    Jpn J Cancer Res; 1998 May; 89(5):548-55. PubMed ID: 9685859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
    Minty A; Ferrara P; Caput D
    Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha, sphingomyelinase, and ceramide inhibit store-operated calcium entry in thyroid FRTL-5 cells.
    Törnquist K; Malm AM; Pasternack M; Kronqvist R; Björklund S; Tuominen R; Slotte JP
    J Biol Chem; 1999 Apr; 274(14):9370-7. PubMed ID: 10092616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of acyl-CoA:cholesterol acyltransferase in Chinese hamster ovary (CHO) cells by short-chain ceramide and dihydroceramide.
    Ridgway ND
    Biochim Biophys Acta; 1995 Apr; 1256(1):39-46. PubMed ID: 7742354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.
    Reiner NE; Ng W; Wilson CB; McMaster WR; Burchett SK
    J Clin Invest; 1990 Jun; 85(6):1914-24. PubMed ID: 2112157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability.
    Hayes MP; Freeman SL; Donnelly RP
    Cytokine; 1995 Jul; 7(5):427-35. PubMed ID: 7578980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione.
    García-Ruiz C; Colell A; Marí M; Morales A; Fernández-Checa JC
    J Biol Chem; 1997 Apr; 272(17):11369-77. PubMed ID: 9111045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.